The effect of exenatide re-exposure on safety and efficacy. (Record no. 18992169)

MARC details
000 -LEADER
fixed length control field 01373 a2200409 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515175909.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200911s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1873-5169
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.peptides.2009.06.026
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Faludi, Peter
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20091113
245 00 - TITLE STATEMENT
Title The effect of exenatide re-exposure on safety and efficacy.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Peptides
Date of publication, distribution, etc. Sep 2009
300 ## - PHYSICAL DESCRIPTION
Extent 1771-4 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Diabetes Mellitus, Type 2
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Hypersensitivity
General subdivision epidemiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Exenatide
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Glycated Hemoglobin
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hypoglycemic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Peptides
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Venoms
General subdivision adverse effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Brodows, Robert
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Burger, Jude
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ivanyi, Tibor
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Braun, Daniel K
773 0# - HOST ITEM ENTRY
Title Peptides
Related parts vol. 30
-- no. 9
-- p. 1771-4
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.peptides.2009.06.026">https://doi.org/10.1016/j.peptides.2009.06.026</a>
Public note Available from publisher's website

No items available.